Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung

International Immunology

Volumn 12, Issue 4, 2000, Pages 537-546

  Echchakir, Hamid ^a   Vergnon, Isabelle ^a   Dorothée, Guillaume ^a   Grunenwald, Dominique ^b   Chouaib, Salem ^a   Mami Chouaib, Fathia ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Nstitut Montsouris   (France)

Author keywords

Cytotoxic T lymphocyte; Non small cell lung cancer; TCR; Tumor infiltrating lymphocyte; Tumor associated antigen

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LARGE CELL CARCINOMA; LUNG; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; LYSIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR CELL LINE; TUMOR REGRESSION;

EID: 0034115382     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.4.537     Document Type: Article

References (29)

1. Boon, T., Coulie, P. and Van Den Eynde, B. 1997. Tumor antigens recognized by T cells. Immunol. Today 18:267.
2. Topalian, S., Solomon, D. and Rosenberg, S. 1989. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 15:3714.
3. Ioannides, C., Freedman, R., Platsoucas, C , Rashed, S. and Kim, Y. 1991. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol. 146:1700.
4. Peoples, G., Davey, M., Goedegebuure, P., Schoof, D. and Eberlein, T. 1993. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. J. Immunol. 151:5472.
5. Caignard, A., Guillard, M., Gaudin, C., Escudier, B., Triebel, F. and Dietrich, P. 1996. In situ demonstration of renal-cell-carcinoma-specific T-cell clones. Int. J. Cancer 66:564.
6. dim+ T cell clones infiltrating a cutaneous T cell lymphoma. Blood 91:4331.
7. Rosenberg, S. 1997. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18:175.
8. Van Den Eynde, B. and Van Der Bruggen, P. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
9. Weynants, P., Lethe, B., Brasseur, F., Marchand, M. and Boon, T. 1994. Expression of mage genes by non-small-cell lung carcinomas. Int. J. Cancer 56:826.
10. Slingluff, C. J., Cox, A., Stover, J. J., Moore, M., Hunt, D. and Engelhard, V. 1994. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res. 54:2731.
11. Yoshino, I., Goedegebuure, P., Peoples, G., Parikh, A., Dimaio, J., Lyerly, H., Gazdar, A. and Eberlein, T. 1994. HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer Cancer Res. 54:3387.
12. Wei, Y. and Hang, Z. 1989. In situ observation of lymphocyte-tumor cell interaction in human lung carcinoma. Immunol. Invest. 18:1095.
13. Echchakir, H., Asselin-Paturel, C., Dorothee, G., Vergnon, I., Grunenwald, D., Chouaib, S. and Mami-Chouaib, F. 1999. Analysis of T-cell-receptor β-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas. Int. J. Cancer 8:205.
14. Melioli, G., Ratto, G., Guastella, M., Meta, M., Biassoni, R., Semino, C., Casartelli, G., Pasquetti, W., Catrullo, A. and Moretta, L. 1994. Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterisation for their use in adoptive immunotherapy. Eur. J. Cancer 30:97.
15. Bennett, W., Pandolfi, F., Grove, B., Hawes, G., Boyle, L., Kradin, R. and Kurnick, J. 1992 Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma. Cancer 69:2379.
16. Yoshino, I., Yano, T., Yoshikai, Y., Murata, M., Sugimachi, K., Kimura, G. and Nomoto, K. 1991. Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int. J. Cancer 47:654.
17. h2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer 77:7.
18. Todd, R., Meuer, S., Romain, P. and Schlossman, S. 1984. A monoclonal antibody that blocks class II histocompatibility-related immune interactions. Hum. Immunol. 10:23.
19. Dietrich, P., Walker, P., Schnuriger, V., Saas, P., Perrin, G., Guillard, M., Gaudin, C. and Caignard, A. 1997. TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int. Immunol. 9:1073.
20. Dufour, E., Carcelain, G., Gaudin, C., Flament, C., Avril, M. and Faure, F. 1997. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines. J. Immunol. 158:3787.
21. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S. and Hercend, T. 1993. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res. 53:3569.
22. Cochet, M., Pannetier, C., Regnault, A., Darche, S., Leclerc, C. and Kourilsky, P. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639.
23. Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M. and Kourilsky, P. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl Acad. Sci. USA 90:4319.
24. Pannetier, C., Even, J. and Kourilsky, P. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
25. Genevee, C., Diu, A., Nierat, J., Caignard, A., Dietrich, P., Ferradini, L., Roman-Roman, S., Triebel, F. and Hercend, T. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
26. Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M. and Kourilsky, P. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807.
27. Ferradini, L., Roman-Roman, S., Azocar, J., Michalaki, H., Triebel, F. and Hercend, T. 1991. Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamilies. Eur. J. Immunol. 21:935.
28. Genevee, C., Farace, F., Chung, V., Diu, A., Raffoux, C., Charron, D., Hercend, T. and Triebel, F. 1994. Influence of human leukocyte antigen genes on TCR V gene segment frequencies. Int. Immunol. 6:1497.
29. Hogan, K., Eisinger, D., Cupp, S. B., Lekstrorn, K., Deacon, D., Shabanowitz, J., Hunt, D., Engelhard, V., Slingluff, C. L. J. and Ross, M. 1998. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res. 58:5144.